Joshua Budhu, Neuro-Oncologist at Memorial Sloan Kettering Cancer Center, shared a post on LinkedIn:
“I’m excited to share our new review on financial toxicity in cancer care, alongside my co-authors Fumiko Ladd Chino and Bridgette Thom, recently published in Current Opinion in Oncology.
Financial toxicity is increasingly recognized as a major adverse effect of cancer treatment, but it is sometimes framed primarily as a patient-level problem.
In this review, we highlight how financial burden arises across multiple levels, including insurance design, employment disruption, health system factors, and policy, and discuss opportunities for intervention using a social-ecological framework.
As cancer treatments advance, ensuring that patients can access and afford care must remain central to improving outcomes and advancing health equity.”
Read the full article here.
Other OncoDaily articles featuring Joshua Budhu.